Trial Profile
Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Pasireotide (Primary)
- Indications Hypoglycaemia
- Focus Therapeutic Use
- 02 Jul 2018 Status changed from not yet recruiting to recruiting.
- 07 May 2018 New trial record